|
Volumn 21, Issue 10 Suppl 1, 2011, Pages
|
Benefits of enhancing the platinum-free interval in the treatment of relapsed ovarian cancer: more than just a hypothesis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PLATINUM DERIVATIVE;
DRUG RESISTANCE;
FEMALE;
HUMAN;
OVARY TUMOR;
RECURRENT DISEASE;
REVIEW;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PLATINUM COMPOUNDS;
RECURRENCE;
MLCS;
MLOWN;
|
EID: 79960057608
PISSN: None
EISSN: 15251438
Source Type: Journal
DOI: 10.1097/igc.0b013e318217b30b Document Type: Review |
Times cited : (6)
|
References (0)
|